Veracyte (VCYT) Free Cash Flow Growth (1y) (2013 - 2026)
Veracyte (VCYT) Free Cash Flow Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -117.95% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 126.04% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 2.94% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 24.06% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -20.33% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 87.85% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 15.26% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 20.67% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -30.93% |
| 10 | Veracyte | 4.76 Bn | 4.50 Bn | 101.16 Mn | 810.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 810.33% |
| Dec 31, 2025 | 67.64% |
| Sep 30, 2025 | 60.29% |
| Jun 30, 2025 | 32.14% |
| Mar 31, 2025 | 133.05% |
| Dec 31, 2024 | 406.80% |
| Sep 30, 2024 | 50.58% |
| Jun 30, 2024 | 93.83% |
| Mar 31, 2024 | -182.40% |
| Dec 31, 2023 | -23.59% |
| Sep 30, 2023 | 246.55% |
| Jun 30, 2023 | 574.52% |
| Mar 31, 2023 | 66.48% |
| Dec 31, 2022 | -2.63% |
| Sep 30, 2022 | 308.93% |
| Jun 30, 2022 | -898.06% |
| Mar 31, 2022 | 72.88% |
| Dec 31, 2021 | 248.19% |
| Sep 30, 2021 | -7.02% |
| Jun 30, 2021 | 104.64% |